Vivo Bio Tech Ltd.

44.16 -1.02 ▼-2.3%

21 February 2024, 04:01:00 PM
Volume: 26,239

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vivobio.com
Market Cap 65.81 Cr.
Enterprise Value(EV) 126.03 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.59 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 17.08 Trailing Twelve Months Ending 2023-12
Industry PE 41.82 Trailing Twelve Months Ending 2023-12
Book Value / Share 35.69 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.24 Calculated using Price: 44.16
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.49 Cr. 14,903,520 Shares
FaceValue 10
About Vivo Bio Tech Ltd.
Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. The company was converted into a public limited company from Jun. 19, 1992. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.

Vivo Bio Tech Ltd. Delivery

Delivered Qty
Traded Qty

Vivo Bio Tech Ltd. Performance

1 Day
-2.26%
1 Week
+1.75%
1 Month
+3.27%
3 Month
+31.59%
6 Month
+57.71%
1 Year
+63.86%
2 Year
+10.40%
5 Year
-24.71%
10 Year
+207.09%

Vivo Bio Tech Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 5.25 9.48 22.17 21.01 10.21 14.85 15.36 5.06 5.44
Return on Capital Employed (%) 4.72 5.96 12.39 15.18 9.58 13.85 18.81 9.32 11.06
Return on Assets (%) 1.14 2.09 5.17 5.64 3.92 7.58 8.02 2.18 2.16

Vivo Bio Tech Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 9 10 13 19 27 33 43 47 52 52
Non Curr. Liab. 4 15 22 15 9 9 15 52 46 44
Curr. Liab. 28 20 17 25 19 21 22 23 25 24
Minority Int.
Equity & Liab. 41 46 51 60 55 62 80 122 123 121
Non Curr. Assets 20 24 32 32 30 35 52 96 91 91
Curr. Assets 22 22 20 28 25 27 27 26 32 30
Misc. Exp. not W/O 0 0 0 0 0 0 0 0 0
Total Assets 41 46 51 60 55 62 80 122 123 121

Vivo Bio Tech Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 18 29 34 47 56 55 52 51 52 48
Other Income 1 1 0 0 0 0 0 0 0 0
Total Income 19 29 35 47 56 55 52 51 52 49
Total Expenditure -15 -25 -27 -36 -46 -43 -34 -35 -30 -26
PBIDT 4 5 8 11 10 13 18 16 22 23
Interest -1 0 -1 -2 -3 -3 -4 -4 -8 -8
Depreciation -3 -3 -4 -5 -5 -5 -6 -7 -9 -9
Taxation 0 0 0 -1 0 0 -3 -2 -2 -2
Exceptional Items
PAT 0 1 3 3 2 4 6 2 3 4
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 1 3 3 2 4 6 2 3 4
Adjusted EPS 0 1 3 3 2 3 4 2 2 3

Vivo Bio Tech Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 3 2 9 -6 11 -1 9 14 17 15
Cash Fr. Inv. -1 -2 -7 -12 -5 -4 -10 -23 -51 -4
Cash Fr. Finan. 0 -1 0 7 -3 1 2 9 35 -11
Net Change 1 -1 1 -11 3 -4 0 0 1 0
Cash & Cash Eqvt 11 11 12 1 4 1 1 1 2 1

Vivo Bio Tech Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 39.84 39.67 42.16 42.16 42.16 42.08 42.08 42.08 42.08
Public 60.16 60.33 57.84 57.84 57.84 57.92 57.92 57.92 57.92
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Vivo Bio Tech Ltd. Announcements

Wed, 14 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed newspaper publication of the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31 2023
Mon, 12 Feb 2024
Board Meeting Outcome for Outcome Of The Board Meeting
With reference to the above cited subject and our letter dated January 30 2024 we bring to your kind notice that the Board of Directors of the Company at their meeting held today i.e. Monday February 12 2024 inter-alia transacted the following business:1. Approved the Un-Audited Standalone & Consolidated Financial Results of the Company for the Third Quarter and Nine Months ended December 31 2023.The meeting commenced at 06.00 p.m. and concluded at 07.15 p.m.This is for your information and records.
Mon, 12 Feb 2024
Un-Audited Financial Results For The Third Quarter And Nine Months Ended December 31 2023
With reference to the above cited subject and our letter dated January 30 2024 we bring to your kind notice that the Board of Directors of the Company at their meeting held today i.e. Monday February 12 2024 inter-alia considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company for the Third Quarter and Nine Months ended December 31 2023.

Vivo Bio Tech Ltd. Technical Scans

Wed, 21 Feb 2024
Closing Below Previous Low Closing Below Previous Low
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
Tue, 20 Feb 2024
High Delivery Percentage High Delivery Percentage

Vivo Bio Tech Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 370,313.36 1,543.40 +0.3%
Cipla Ltd. 116,866.14 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. 105,898.11 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. 97,179.74 6,760.15 +0.0%
Divi's Laboratories Ltd. 96,854.88 3,649.10 -1.7%
Zydus Lifesciences Ltd. 90,440.44 893.80 -0.2%
Torrent Pharmaceuticals Ltd. 88,043.20 2,603.00 -1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.58 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 31.52 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.26 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.12 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 70.03 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.41 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 58.93 2,603.00 -1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.94 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 4.51 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.94 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.39 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.65 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.31 2,603.00 -1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,603.00 -1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,603.00 -1.6%

Vivo Bio Tech Ltd. FAQ's

What is Vivo Bio Tech share price?

Can I buy Vivo Bio Tech shares now?

What is the Market Cap of Vivo Bio Tech?

What are the key metrics to analyse Vivo Bio Tech?

What is the 52 Week High and Low of Vivo Bio Tech?

What is the trend of Vivo Bio Tech share price?